Alison Muller
October 22, 2024
When you think about Artificial Intelligence (AI), what image comes up? Does this?
Or this (if you’re a movie buff of a certain age)?
We’ve come a long way since Stanley Kubrick’s 2001: A Space Odyssey.
Promising recent developments include Eli Lilly and Company appointing its first Chief AI Officer. The FDA’s Digital Advisory Health Committee is soon discussing total product lifecycle considerations for GenAI-enabled medical devices. And a leading technological research and consulting firm’s report from Q2 ’24 notes how a group of early AI adopters is “… distinctly outpacing the rest of organizations in life sciences … ” when it comes to AI deployments for drug discovery.
AI And The Human Element
AI is rapidly integrating into the biopharma industry, and at ACTO, we see an opportunity for AI to enhance the human element by empowering field reps, MSLs, and other professionals to deliver accurate, real-time information right when it’s needed. This can ultimately improve both patient safety and business outcomes.
When engaging with healthcare providers (HCPs), field professionals often face the challenge of needing to quickly retrieve detailed clinical and product information. With the rise of AI tools like ChatGPT, these chatbots offer a promising solution by providing instant answers and support, enabling pharma field teams to deliver timely, precise messaging during these critical interactions.
Well, don’t open those pod bay doors just yet.
There is a reason many top pharma brands have outright banned the use of ChatGPT. It involves the fact that they don’t meet requirements specific to the Life Sciences industry.
For these tools to be adopted and successful, GenAI knowledge assistants must be:
- Life Sciences Fluent: Fine-tuned specifically for the Life Sciences industry.
- Secure: Certified to protect data privacy and security.
- Compliant: Designed to comply with FDA regulations.
- Controlled: Governed by rules that ensure it only references MLR-approved content.
So how can such a knowledge assistant be successfully implemented and accepted in our highly regulated industry?
AI Is Already At The Table. Where Are You With Your Plans?
When implemented correctly, GenAI knowledge assistants can improve decision-making and efficiency, ensuring the right information is available at the right time without violating compliance standards. They can go a long way to helping field teams build trust and confidence more quickly with HCPs.
To learn how to build a successful GenAI Knowledge Assistant Pilot Program, download this guide. For more details and next steps, contact us.